• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Acta Med Okayama . Secondary Polymyalgia Rheumatica Following SARS-CoV-2 Infection

tetano

Editor, Senior Moderator
Acta Med Okayama


. 2024 Dec;78(6):465-468.
doi: 10.18926/AMO/67873. Secondary Polymyalgia Rheumatica Following SARS-CoV-2 Infection

Kazuki Ocho[SUP] 1 [/SUP], Hideharu Hagiya[SUP] 2 [/SUP], Hisashi Ishikawa[SUP] 1 [/SUP], Fumio Otsuka[SUP] 3 [/SUP]



Affiliations
Free article Abstract

An 81-year-old Japanese man with a medical history of diabetes mellitus and hypertension was diagnosed with the novel coronavirus disease 2019 (COVID-19). The patient developed pain in the bilateral shoulders and hips 3 days after the disease onset and presented to our outpatient clinic after 1 month. Referring to diagnostic criteria, we diagnosed him with polymyalgia rheumatica (PMR). We initiated prednisolone at 15 mg per day and his symptoms improved immediately. The clinical course of the patient indicated that the SARS-CoV-2 infection triggered the onset of autoimmune disease, PMR in this case.

Keywords: COVID-19; SARS-CoV-2; autoimmune diseases; human leukocyte antigen; polymyalgia rheumatica.

 
Back
Top Bottom